LISATA THERAPEUTICS, INC. Restricted Cash, Current
LISATA THERAPEUTICS, INC. (LSTA) had Restricted Cash, Current of $0 as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2019-03-14
- 2018-12-31: Restricted Cash, Current $0.00.
- 2018-09-30: Restricted Cash, Current $0.00.
- 2018-06-30: Restricted Cash, Current $0.00.
- 2018-03-31: Restricted Cash, Current $5.01M.
| Period end | Restricted Cash, Current | Restricted Cash, Current as first filed |
|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $5.01M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $5.00M 10-K · filed 2019-03-14 | $5.00M 10-K · filed 2018-03-22 |
| 2017-09-30 | $5.00M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $5.00M 10-Q · filed 2017-08-10 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |